Inventor
Thomas E. Mabry
Inventor
Indianapolis, IN, US
Overview
Patents· 45 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
C07DHeterocyclic compounds25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07CAcyclic or carbocyclic compounds10%
C07KPeptides7%
C07HSugars5%
Y02PClimate change mitigation technologies in the production or processing of goods3%
PatentTitleYear
8,778,984'Aldosterone synthase inhibitor'20148,153,807'Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1'20127,994,176'Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1'20117,981,918'Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1'20117,968,585'Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1'20117,820,659'Cyclohexylimidiazole lactam derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase 1'20107,713,979'Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1'20107,153,847'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds'20066,958,330'Polycyclic α-amino-ε-caprolactams and related compounds'20056,951,854'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds'20056,906,056'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds'20056,888,022'Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis'20056,861,558'Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis'20056,767,918'N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20046,683,075'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use'20046,667,305'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,653,303'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,642,261'N-(aryl/heteroarylacety) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,635,632'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,632,811'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,579,867'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,569,851'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,559,141'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,544,978'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,541,466'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting -amyloid peptide release and/or its synthesis by use of such compounds'20036,476,263'Compounds for inhibiting -amyloid peptide release and/or its synthesis'20026,333,351'N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds'20016,313,152'N(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds'20016,262,302'N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds'20016,211,235'Compounds for inhibiting .beta.-amyloid peptide release and/or its synthesis'20016,207,710'Compounds for inhibiting .beta.-amyloid peptide release and/or its synthesis'20016,191,166'Methods and compounds for inhibiting .beta.-amyloid peptide release and/or its synthesis'20016,172,073'Compounds having effects on serotonin-related systems'20016,153,652'N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds'20006,117,901'N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use'20006,046,215'Inhibition of serotonin reuptake'20005,846,982'Inhibition of serotonin reuptake'19985,789,402'Compounds having effects on serotonin-related systems'19985,744,597'Stereoselective anion glycosylation process for preparing 2\'-deoxy-2\',2\'-difluoronucleosides and 2\'-deoxy-2\'-fluoronucleosides'19985,627,196'Compounds having effects on serotonin-related systems'19975,594,155'Anomeric fluororibosyl amines'19975,541,345'Anomeric fluororibosyl amines'19965,491,166'Inhibitors of HIV protease useful for the treatment of AIDS'19965,480,992'Anomeric fluororibosyl amines'19965,453,499'Process for preparing alpha-anomer enriched 1-halo-2-deoxy-2,2-difluoro-D-ribofuranosyl derivatives'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2014Based in Indianapolis, IN, US· patent location history
1996–2014Patents assigned to LILLY CO ELI (44)· patent assignee history
2000–2004Patents assigned to ATHENA NEUROSCIENCES INC (14)· patent assignee history
2000–2005Patents assigned to ELAN PHARM INC (7)· patent assignee history
2012–2014Patents assigned to MABRY THOMAS EDWARD (2)· patent assignee history
2014Patents assigned to BELL MICHAEL GREGORY (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LILLY CO ELI | 44 | 1996–2014 |
| ATHENA NEUROSCIENCES INC | 14 | 2000–2004 |
| ELAN PHARM INC | 7 | 2000–2005 |
| MABRY THOMAS EDWARDself | 2 | 2012–2014 |
| BELL MICHAEL GREGORY | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Indianapolis, IN, US | 45 | 1995–2014 |